中国糖尿病设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按管理设备(胰岛素泵、胰岛素注射器、胰岛素筒和一次性笔)和监测设备(自我监测血糖和连续血糖监测)进行细分。

市场快照

Chinese Diabetes Care Devices Market Overview
Study Period: 2016-2027
Base Year: 2021
CAGR: >5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计中国糖尿病护理设备市场在预测期内(2021-2026 年)的复合年增长率将超过 6%。在预测期内,由于该地区糖尿病患病率的上升,预计中国将主导亚太地区的市场。从胰岛素注射到胰岛素泵,胰岛素输送系统技术取得了重大进展。技术创新和进步为测量血糖水平提供了许多便利。监测血糖水平的一项进步是引入连续血糖监测设备。

报告范围

该研究对中国糖尿病护理设备市场进行了详细分析,包括市场份额、规模、预测和行业概况。

By Device
By Monitoring Devices, (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Receivers (Receivers and Transmitters)
By Management Devices, (Value and Volume, 2016 - 2026)
Insulin Delivery Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Disposable Pens
Insulin Cartridges in Reusable pens
Insulin Jet Injectors

Report scope can be customized per your requirements. Click here.

主要市场趋势

糖尿病人口增加

中国在糖尿病人口最多的国家中排名第三。2 型糖尿病 (T2D) 的发病率在过去十年中迅速增加,已成为中国面临的主要公共卫生挑战。中国糖尿病市场的增长是由糖尿病患者的增加、高热量饮食的增长和久坐的生活方式推动的。这导致该国的糖尿病患者人数创下了世界最高纪录,到 2020 年将达到 1.26 亿人,约占人口的 8%。2020年约有1.26亿人患有糖尿病,成人患病率为10.9%。在1.26亿糖尿病患者中,1249万为1型患者,1.142亿为2型患者。

China Diabetes Population

自测血糖仪2019年中国糖尿病设备市场占有率最高

2020 年中国自我监测血糖(SMBG)设备市场价值 9.7 亿美元,预计到 2026 年将达到 14 亿美元。预测期内的复合年增长率也可能超过 6.5%( 2021 - 2026 年)。在SBGM市场中,血糖试纸和柳叶刀合计占据86.9%的份额,而血糖仪设备占据了13%的份额。与血糖仪试纸和血糖仪柳叶刀相比,血糖仪设备的复合年增长率很高,在预测期内估计为 8.3%。该国糖尿病患病率稳步上升,截至目前,近9%的成年人口患有糖尿病。然而,人们对监测血糖水平的好处缺乏认识,获得医疗保健服务的机会少,健康意识薄弱,

China Devices

竞争格局

制造商不断创新是为了在市场上竞争和奋斗。雅培、美敦力等主要企业通过并购等无机市场战略来确立市场主导地位,同时也坚持有机增长战略,这从这些公司的研发支出中可以看出。

RECENT DEVELOPMENTS

In May 2021, Chinese medical device innovation hub Dinova Medtech and US-based medical device company Metronom Health have established a joint venture to develop and sell a continuous glucose monitoring system in China.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Dynamics

      1. 4.2.1 Market Drivers

      2. 4.2.2 Market Restraints

    3. 4.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.3.1 Bargaining Power of Suppliers

      2. 4.3.2 Bargaining Power of Consumers

      3. 4.3.3 Threat of New Entrants

      4. 4.3.4 Threat of Substitute Products and Services

      5. 4.3.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Device

      1. 5.1.1 By Monitoring Devices, (Value and Volume, 2016 - 2026)

        1. 5.1.1.1 Self-monitoring Blood Glucose Devices

          1. 5.1.1.1.1 Glucometer Devices

          2. 5.1.1.1.2 Test Strips

          3. 5.1.1.1.3 Lancets

        2. 5.1.1.2 Continuous Glucose Monitoring

          1. 5.1.1.2.1 Sensors

          2. 5.1.1.2.2 Receivers (Receivers and Transmitters)

      2. 5.1.2 By Management Devices, (Value and Volume, 2016 - 2026)

        1. 5.1.2.1 Insulin Delivery Devices

          1. 5.1.2.1.1 Insulin Pump

            1. 5.1.2.1.1.1 Insulin Pump Device

            2. 5.1.2.1.1.2 Insulin Pump Reservoir

            3. 5.1.2.1.1.3 Infusion Set

          2. 5.1.2.1.2 Insulin Syringes

          3. 5.1.2.1.3 Insulin Disposable Pens

          4. 5.1.2.1.4 Insulin Cartridges in Reusable pens

          5. 5.1.2.1.5 Insulin Jet Injectors

  6. 6. MARKET INDICATORS

    1. 6.1 Type 1 Diabetes Population (2016 - 2026)

    2. 6.2 Type 2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Roche

      2. 7.1.2 Abbott

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Novo Nordisk

      5. 7.1.5 Becton, Dickinson & Company

      6. 7.1.6 Medtronic

      7. 7.1.7 SinoCare

      8. 7.1.8 Sanofi

      9. 7.1.9 ARKRAY Inc.

      10. 7.1.10 Ascensia Diabetes Care

      11. 7.1.11 ACON Laboratories Inc.

      12. 7.1.12 Eli Lilly

      13. 7.1.13 Bionime Corporation

      14. 7.1.14 Rossmax International Ltd

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Diabetes Devices Market market is studied from 2016 - 2027.

The China Diabetes Devices Market is growing at a CAGR of >5% over the next 5 years.

The China Diabetes Devices Market is valued at 6 Billion USD in 2016.

The China Diabetes Devices Market is valued at 8 Billion USD in 2027.

Abbott, Medtronics, Roche, Becton, Dickinson & Company, Dexcom are the major companies operating in China Diabetes Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!